LOS ANGELES, July 12, 2022 /PRNewswire/ -- Turn Therapeutics, a biotechnology company developing innovative products for infectious disease, advanced wound care, and dermatology, today announced ...

New Logo. The study evaluated the immunological inhibitory effects of the topical application of Turn Therapeutics' candidate, GX-03, in an eczema model using C57BL/6 mice and a well-established ...

LOS ANGELES--(BUSINESS WIRE)--Turn Therapeutics has successfully maintained a live vaccine's viability for 24 hours at room temperature using its oil suspension technology.This breakthrough ...

WESTLAKE VILLAGE, Calif., December 12, 2024--Turn Therapeutics announced a $75 million investment commitment from GEM Global Yield LLC SCS, a private equity and alternative investment group.

LOS ANGELES--(BUSINESS WIRE)--In a widely cited in-vivo model of atopic dermatitis, Turn Therapeutics' atopic dermatitis candidate showed a dramatic reduction in disease severity versus placebo.At ...

LOS ANGELES, Oct. 11, 2019 /PRNewswire/ -- Turn Therapeutics™, Inc., a Los Angeles-based pharmaceutical and medical device company, has announced FDA clearance of Protego™ Antimicrobial Wound ...

Turn Therapeutics, a biotechnology company specializing in advanced wound care and infection control, today announced enrollment of the first subjects in its COVID-19 treatment and prevention ...

WESTLAKE VILLAGE, Calif., Aug. 5, 2024 /PRNewswire/ -- Turn Therapeutics, a pharmaceutical and medical device company focused on immunology, advanced wound care, and dermatology, announced today ...

WESTLAKE VILLAGE, Calif., Aug. 5, 2024 /PRNewswire/ -- Turn Therapeutics, a pharmaceutical and medical device company focused on immunology, advanced wound care, and dermatology, announced today ...